Sophie Trang
About Sophie Trang
Sophie Trang serves as the Director of Shareholder Services at Inari Medical, a position she has held since 2021. With extensive experience in financial planning and operational analysis, she has worked in various roles across multiple companies, demonstrating expertise in risk assessment and business process improvement.
Work at Inari Medical
Sophie Trang has been serving as the Director of Shareholder Services at Inari Medical since 2021. In this role, she oversees shareholder communications and ensures effective management of shareholder relations. Prior to her current position, she worked as a Senior Manager in Shareholder Services at Inari Medical from 2020 to 2021. Her tenure at Inari Medical has allowed her to leverage her extensive experience in financial planning and analysis to enhance shareholder engagement.
Education and Expertise
Sophie Trang studied at California State University, Long Beach, where she completed her degree from 1985 to 1989. She specializes in Operational Analysis, focusing on evaluating the efficiency and effectiveness of business operations. Additionally, she possesses expertise in Risk Assessment, identifying and mitigating financial risks. Her skills also include SOX Testing, ensuring compliance with the Sarbanes-Oxley Act, and Business Process Re-Engineering, aimed at improving business processes.
Background in Financial Consulting
Sophie Trang has a diverse background in financial consulting, having worked at several organizations. She served as a Financial Consultant at REAL MEX FOOD from 2011 to 2013. Prior to that, she was a Consultant at RGP from 2015 to 2017. Her experience in these roles has contributed to her strong analytical skills and understanding of financial operations, which she has applied throughout her career.
Career Progression in Financial Planning
Throughout her career, Sophie Trang has held various positions in financial planning and analysis. She worked at Mallinckrodt Pharmaceuticals as Manager of Financial Planning and Analysis from 2013 to 2015. She also served as Director of Financial Planning Analysis at AIVITA Biomedical from 2018 to 2019. Her roles have consistently involved strategic financial oversight and analysis, demonstrating her capability in driving financial strategies.
Previous Roles in Financial Analysis
Sophie Trang has held several significant positions in financial analysis. She was a Principal Financial Analyst at both Kingston Technology from 2010 to 2011 and Allergan from 2007 to 2009. Earlier in her career, she worked as a Senior Financial Analyst at CB Richard Ellis for six months in 2006. These roles have equipped her with a robust understanding of financial metrics and analysis, contributing to her effectiveness in her current position.